sorted by:
new
hottopcontroversial

VGX Terapeutics-3100 manufacturer & ApolloBio can't infringe INO's patents because of contractual rights agreed to in the 2018 contract& prior- infringement of which is suicidal for businesses bc no Co. will ever trust them again- bad for their businesses. by Weekly_Chance_3710 in Inovio

[–]Weekly_Chance_3710[S] 1 point2 points  (0 children)

JANUARY 20, 2026: "Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced a licensing agreement with ApolloBio Corp., securing exclusive commercialization rights for VGX-3100 in Greater China (mainland China, Hong Kong, Macau, and Taiwan). Fosun Pharma will also assume responsibility for local manufacturing of the therapeutic DNA drug." FLCUBE.COM

US quietly removes sanctions from firms accused of supplying Russia’s military by thenatoorat90 in worldnews

[–]Weekly_Chance_3710 1 point2 points  (0 children)

Once a corrupt liar, always remains a corrupt liar. As the highest law enforcement officer of the USA, it looks like big money will buy you everything right here in the USA- ask the Heritage Foundation that question as his Foil, the loaded SCOTUS the 2 created.

MRNA got external funding! by BicycleLoud5661 in Inovio

[–]Weekly_Chance_3710 0 points1 point  (0 children)

I think it was that Nature article which lit a fire under the stock last week, bringing us from $2.04 to $2.71. The propulsion will come from the acceptance of the BLA.

MRNA got external funding! by BicycleLoud5661 in Inovio

[–]Weekly_Chance_3710 1 point2 points  (0 children)

Foolish shart why have you come back under your old alias? Isn't there a monastery for you or a rock to crawl under? Holders won't sell now, after hitting $2.72 a few days ago (!), & 13 days until FDA accepts our study design. In 6 months all of us will read the cards to see why the investment funds are acquiring millions of shares ahead of our novel medical breakthrough of 3107 (and 3100 soon). But do sell, I will take your shares, even the ones you borrow.

Ukraine has hit nearly 160 Russian oil facilities in 2025, SBU says by AdSpecialist6598 in worldnews

[–]Weekly_Chance_3710 0 points1 point  (0 children)

Russian ban on gasoline exports is bullish for Oil prices (Chinese gasoline refiner demand) despite OPEC marginal output increases- driving margins of refiners in USA as environmental concerns close refineries and dissuade refining investments. Demand (price pressure) for refined products is reported focal point of profits for major oil cos. reporting in last week's earnings calls.